Myocardial Infarct Size in Patients on Long-Term Statin Therapy Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

American Journal of Cardiology

Volumn 116, Issue 12, 2015, Pages 1791-1797

  Marenzi, Giancarlo ^a,b   Cosentino, Nicola ^a,b   Cortinovis, Sarah ^a,b   Milazzo, Valentina ^a,b   Rubino, Mara ^a,b   Cabiati, Angelo ^a,b   De Metrio, Monica ^a,b   Moltrasio, Marco ^a,b   Lauri, Gianfranco ^a,b   Campodonico, Jeness ^a,b   Pontone, Gianluca ^a,b   Andreini, Daniele ^a,b   Bonomi, Alice ^a,b   Veglia, Fabrizio ^a,b   Bartorelli, Antonio ^a,b  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TROPONIN I;

ADULT; ARTICLE; BLOOD VESSEL OCCLUSION; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROVASCULAR OBSTRUCTION; MYOCARDIAL SALVAGE INDEX; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME; ANGIOCARDIOGRAPHY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECTS; ELECTROCARDIOGRAPHY; FOLLOW UP; MIDDLE AGED; MYOCARDIAL INFARCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE CARE; PROCEDURES; TIME;

CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREOPERATIVE CARE; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84952872841     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.09.016     Document Type: Article

References (30)

1. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
2. E.C. Keeley, and L.D. Hillis Primary PCI for myocardial infarction with ST-segment elevation N Engl J Med 356 2007 47 54
3. G. Ndrepepa, K. Tiroch, M. Fusaro, D. Keta, M. Seyfarth, R.A. Byrne, J. Pache, P. Alger, J. Mehilli, A. Schömig, and A. Kastrati 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction J Am Coll Cardiol 55 2010 2383 2389
4. G. Niccoli, F. Burzotta, L. Galiuto, and F. Crea Myocardial no-reflow in humans J Am Coll Cardiol 54 2009 281 292
5. F. Crea Coronary microvascular obstruction - a puzzle with many pieces N Engl J Med 372 2015 1464 1465
6. T. Bauer, M. Bohm, R. Zahn, C. Junger, O. Koeth, A. Gitt, K. Bestehorn, J. Senges, and U. Zeymer Effect of chronic statin pretreatment on hospital outcome in patients with acute non-ST-elevation myocardial infarction J Cardiovasc Pharmacol 53 2009 132 136
7. G. Patti, V. Pasceri, G. Colonna, M. Miglionico, D. Fischetti, G. Sardella, A. Montinaro, and G. Di Sciascio Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial J Am Coll Cardiol 49 2007 1272 1278
8. V. Pasceri, G. Patti, A. Nusca, C. Pristipino, G. Richichi, G. Di Sciascio ARMYDA Investigators Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study Circulation 110 2004 674 678
9. K.H. Yun, M.H. Jeong, S.K. Oh, S.J. Rhee, E.M. Park, E.M. Lee, N.J. Yoo, N.H. Kim, Y.K. Ahn, and J.W. Jeong The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome Int J Cardiol 137 2009 246 251
10. X.D. Li, Y.J. Yang, Y.J. Geng, Y.T. Cheng, H.T. Zhang, J.L. Zhao, J.Q. Yuan, and R.L. Gao The cardioprotection of simvastatin in reperfused swine hearts relates to the inhibition of myocardial edema by modulating aquaporins via the PKA pathway Int J Cardiol 167 2013 2657 2666
11. E.O. Weinberg, M. Scherrer-Crosbie, M.H. Picard, B.A. Nasseri, C. MacGillivray, J. Gannon, Q. Lian, K.D. Bloch, and R.T. Lee Rosuvastatin reduces experimental left ventricular infarct size after ischemia-reperfusion injury but not total coronary occlusion Am J Physiol Heart Circ Physiol 288 2005 H1802 H1809
12. G. Fuernau, I. Eitel, J. Wöhrle, S. Kerber, B. Lauer, M. Pauschinger, J. Schwab, R. Birkemeyer, S. Pfeiffer, M. Mende, O. Brosteanu, P. Neuhaus, S. Desch, S. de Waha, M. Gutberlet, G. Schuler, and H. Thiele Impact of long-term statin pretreatment on myocardial damage in ST elevation myocardial infarction (from the AIDA STEMI CMR Substudy) Am J Cardiol 114 2014 503 509
13. J.S. Kim, J. Kim, D. Choi, C.J. Lee, S.H. Lee, Y.G. Ko, M.K. Hong, B.K. Kim, S.J. Oh, D.W. Jeon, J.Y. Yang, J.R. Cho, N.H. Lee, Y.H. Cho, D.K. Cho, and Y. Jang Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial JACC Cardiovasc Interv 3 2010 332 339
14. S. Post, M.C. Post, B.J. van den Branden, F.D. Eefting, M.J. Goumans, P.R. Stella, H.W. van Es, T.X. Wildbergh, B.J. Rensing, and P.A. Doevendans Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial Catheter Cardiovasc Interv 80 2012 756 765
15. J.Y. Hahn, H.J. Kim, Y.J. Choi, S.H. Jo, H.J. Kim, S. Lee, K.J. Ahn, Y.B. Song, J.H. Choi, S.H. Choi, Y.J. Choi, K.H. Lee, S.H. Lee, and H.C. Gwon Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Am Heart J 162 2011 1026 1033
16. Y.G. Ko, H. Won, D.H. Shin, J.S. Kim, B.K. Kim, D. Choi, M.K. Hong, J.H. Bae, S. Lee, D.S. Lim, and Y. Jang Efficacy of early intensive rosuvastatin therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (ROSEMARY Study) Am J Cardiol 114 2014 29 35
17. J.W. Kim, K.H. Yun, E.K. Kim, Y.C. Kim, D.Y. Joe, J.S. Ko, S.J. Rhee, E.M. Lee, N.J. Yoo, N.H. Kim, S.K. Oh, and J.W. Jeong Effect of high dose rosuvastatin loading before primary percutaneous coronary intervention on infarct size in patients with ST-segment elevation myocardial infarction Korean Circ J 44 2014 76 81
18. TIMI Study Group The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. TIMI study group N Engl J Med 312 1985 932 936
19. J. Schulz-Menger, D.A. Bluemke, J. Bremerich, S.D. Flamm, M.A. Fogel, M.G. Friedrich, R.J. Kim, F. von Knobelsdorff-Brenkenhoff, C.M. Kramer, D.J. Pennell, S. Plein, and E. Nagel Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing J Cardiovasc Magn Reson 15 2013 35
20. O. Bondarenko, A.M. Beek, M.B. Hofman, H.P. Kühl, J.W. Twisk, W.G. van Dockum, C.A. Visser, and A.C. van Rossum Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast enhanced CMR J Cardiovasc Magn Reson 7 2005 481 485
21. P. Gazzerro, M.C. Proto, G. Gangemi, A.M. Malfitano, E. Ciaglia, S. Pisanti, A. Santoro, C. Laezza, and M. Bifulco Pharmacological actions of statins: a critical appraisal in the management of cancer Pharmacol Rev 64 2012 102 146
22. A.A. Heestermans, J.W. van Werkum, D. Taubert, T.H. Seesing, N. von Beckerath, C.M. Hackeng, E. Schömig, F.W. Verheugt, and J.M. Ten Berg Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction Thromb Res 122 2008 776 781
23. S. Wassmann, A. Faul, B. Hennen, B. Scheller, M. Bohm, and G. Nickenig Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function Circ Res 93 2003 98 103
24. T. Hinoi, S. Matsuo, F. Tadehara, S. Tsujiyama, and M. Yamakido Acute effect of atorvastatin on coronary circulation measured by transthoracic Doppler echocardiography in patients without coronary artery disease by angiography Am J Cardiol 96 2005 89 91
25. K.K. Ray, and C.P. Cannon Early time to benefit with intensive statin treatment: could it be the pleiotropic effects? Am J Cardiol 96 2005 54 60
26. S. Matetzky, P. Fefer, B. Shenkman, M. Shechter, I. Novikov, N. Savion, D. Varon, and H. Hod Statins have an early antiplatelet effect in patients with acute myocardial infarction Platelets 22 2011 103 110
27. T. Celik, H. Kursaklioglu, A. Iyisoy, S. Kose, S. Kilic, B. Amasyali, E. Kardesoglu, and E. Isik The effects of prior use of atorvastatin on coronary blood flow after primary percutaneous coronary intervention in patients presenting with acute myocardial infarction Coron Artery Dis 16 2005 321 326
28. K. Iwakura, H. Ito, S. Kawano, A. Okamura, T. Kurotobi, M. Date, K. Inoue, and K. Fujii Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfuse acute myocardial infarction Eur Heart J 27 2006 534 539
29. R. Hoffmann, P. Haager, H. Suliman, P. Christott, P. Radke, R. Blindt, and M. Kelm Effect of statin therapy before Q-wave myocardial infarction o myocardial perfusion Am J Cardiol 101 2008 139 143
30. E.I. Lev, R. Kornowski, H. Vaknin-Assa, I. Ben-Dor, D. Brosh, I. Teplitsky, S. Fuchs, A. Battler, and A. Assali Effect of previous treatment with statins on outcome of patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention Am J Cardiol 103 2009 165 169